What is a predictive marker?

predictive marker is a genetic indicator that can throw light on how well the patient reacts to treatment. Research on the use of predictive markers primarily includes cancer, especially breasts, but treatment of other diseases can be a goal for a well. Laboratory testing can be used to identify specific genetic areas of interest as to whether scientists want to identify a new brand or project the patient during the development of the treatment plan. Professional clinic organizations regularly publish instructions on the indicators they identified and how to use them in therapy. Some may offer indicators that the tumor is chemo-resistant; Chemotherapy may not be effective at all, or the possibilities of chemotherapy may be more limited. Others suggest susceptibility or indicate that the tumor is very likely to respond to a particular type of chemotherapy. This information can lead the development of the effective treatment plan.

Using predictive markers, it allows you to adapt to the patient's treatment. If the patient has chEmo-resistant tumor, which is unlikely to be reduced in response to any available treatment, can make more sense to focus on as much resection as possible and by radiation therapy to target persistent cells. Exhaustive seating of chemotherapy can be skipped because it is unlikely that they would offer the patient any benefits and could worsen the quality of life.

On the contrary, the patient's predictive marker may indicate that a specific drug program or a combination of chemotherapy could be highly effective. This would allow the patient to start getting the best medicines very soon in treatment, rather than have to try several regimes to find the right one. Attack cancer soon can increase the chance of success. Brands can also indicate whether Growth is likely to metastasize, and if the patient's genetic relationships are also at risk.

Křeka

are not the only conditions that can benefit from predictive researchmarkers. People infected with certain organisms such as human immunodeficiency virus (HIV) and Hepatitis C virus can carry predictive markers that can provide information on how well they respond to treatment. This can help their medical teams to determine how to proceed with treatment and can reveal which possibilities would be best for the patient. In addition, predictive marker can offer insight into the forecast and survival rate, which may be important for patients who want to make informed decisions.